HilleVax, Inc. (HLVX)
USD 1.86
(-2.11%)
USD 1.86
(-2.11%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -86.78 Million | -61.98 Million | -7.29 Million | -1.27 Million | -474 Thousand |
| Net Income | -123.56 Million | -159.8 Million | -102.4 Million | -2.1 Million | -673 Thousand |
| Depreciation & Amortization | 2.15 Million | 1000.00 | 3000.00 | - | - |
| Deferred income taxes | -14.4 Million | - | 25.91 Million | - | - |
| Stock-based compensation | 13.59 Million | 3 Million | 67 Thousand | - | - |
| Change in working capital | 22.84 Million | -5.4 Million | 11.27 Million | 52 Thousand | 168 Thousand |
| Other non-cash items | 12.59 Million | 100.21 Million | 57.86 Million | 779 Thousand | 31 Thousand |
| Investing Cash Flow | -94.63 Million | -6.51 Million | -2.8 Million | - | - |
| Investments in PPE | -10.74 Million | -6.51 Million | -2.8 Million | - | - |
| Acquisitions | 83.89 Thousand | - | - | - | - |
| Investment purchases | -143.79 Million | - | - | - | - |
| Sales/Maturities of investments | 59.9 Million | - | - | - | - |
| Other Investing Activities | -83.89 Thousand | -2500.00 | -2763.00 | - | - |
| Financing Cash Flow | 118.69 Million | 224.96 Million | 134.21 Million | 1.32 Million | 877 Thousand |
| Debt repayment | -9.8 Million | -14.66 Million | -135 Million | -1.32 Million | -875 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 108.89 Million | 230 Million | 1000.00 | 1000.00 | 2000.00 |
| Other Financing Activities | 19.6 Million | 9.62 Million | 269.21 Million | 2.65 Million | 877 Thousand |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | 14.4 Million | 2.81 Million | 8.54 Million | 23 Thousand | - |
| Inventory | - | - | - | - | - |
| Other working capital | 8.43 Million | -8.21 Million | 2.72 Million | 29 Thousand | 168 Thousand |
| Cash at beginning of period | 279.4 Million | 124.56 Million | 457 Thousand | 403 Thousand | - |
| Cash at end of period | 216.67 Million | 281.03 Million | 124.56 Million | 457 Thousand | 403 Thousand |
| Capital Expenditure | -10.74 Million | -6.51 Million | -2.8 Million | - | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -62.72 Million | 156.46 Million | 124.1 Million | 54 Thousand | 403 Thousand |
| Free Cash Flow | -97.53 Million | -68.5 Million | -10.1 Million | -1.27 Million | -474 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -40.66 Million | -46.82 Million | -36.96 Million | -123.56 Million | -31.81 Million | -27.9 Million |
| Depreciation & Amortization | 795 Thousand | 707 Thousand | 724 Thousand | 2.15 Million | 653 Thousand | 418 Thousand |
| Deferred income taxes | - | - | 4.66 Million | -14.4 Million | -1.27 Million | -603 Thousand |
| Stock-based compensation | 6.06 Million | 5.19 Million | 3.75 Million | 13.59 Million | 3.94 Million | 3.24 Million |
| Change in working capital | -3.04 Million | -6.43 Million | 11.58 Million | 22.84 Million | 1.35 Million | 2.18 Million |
| Other non-cash items | 18.19 Million | 26.14 Million | -5.38 Million | 12.59 Million | 325 Thousand | 240 Thousand |
| Investing Cash Flow | -3.46 Million | -57.66 Million | 29.46 Million | -94.63 Million | -31.17 Million | -89.94 Million |
| Investments in PPE | -47 Thousand | -13.97 Million | -738 Thousand | -10.74 Million | -2.18 Million | -4.83 Million |
| Acquisitions | - | - | -30.2 Thousand | 83.89 Thousand | -15 Million | - |
| Investment purchases | -46.92 Million | -92.68 Million | -14.69 Million | -143.79 Million | -43.98 Million | -85.1 Million |
| Sales/Maturities of investments | 43.5 Million | 49 Million | 44.9 Million | 59.9 Million | 15 Million | - |
| Other Investing Activities | -3421.00 | -57.5 Thousand | 30.2 Thousand | -83.89 Thousand | 15 Million | -85.1 Thousand |
| Financing Cash Flow | 615 Thousand | 15.06 Million | 313 Thousand | 118.69 Million | 108.1 Million | 10.19 Million |
| Debt repayment | - | - | -9.8 Million | -9.8 Million | - | -9.8 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 615 Thousand | 15.06 Million | 313 Thousand | 108.89 Million | 108.1 Million | 398 Thousand |
| Other Financing Activities | 615.00 | 15.06 Thousand | 313.00 | 19.6 Million | 7000.00 | 19.6 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -3.46 Million | -5.17 Million | 9.87 Million | 14.4 Million | -672 Thousand | 747 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 426 Thousand | -1.25 Million | 1.71 Million | 8.43 Million | 2.03 Million | 1.43 Million |
| Cash at beginning of period | 141.07 Million | 216.67 Million | 208.5 Million | 279.4 Million | 160 Million | 262.17 Million |
| Cash at end of period | 108.44 Million | 141.07 Million | 216.67 Million | 216.67 Million | 210.13 Million | 160 Million |
| Capital Expenditure | -47 Thousand | -13.97 Million | -738 Thousand | -10.74 Million | -2.18 Million | -4.83 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -32.63 Million | -75.6 Million | 8.17 Million | -62.72 Million | 50.12 Million | -102.16 Million |
| Free Cash Flow | -29.82 Million | -46.98 Million | -22.34 Million | -97.53 Million | -28.99 Million | -27.25 Million |
NTDOY
SOLI
ORV
ZODIACLOTH
SPXCF
TCEHY